{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T12:36:33Z","timestamp":1758630993813},"reference-count":9,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,4,24]]},"DOI":"10.1182\/blood-2014-02-553693","type":"journal-article","created":{"date-parts":[[2014,4,24]],"date-time":"2014-04-24T12:29:54Z","timestamp":1398342594000},"page":"2740-2742","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":11,"title":["Rituximab maintenance obviates the poor prognosis associated with circulating lymphoma cells in patients with follicular lymphoma"],"prefix":"10.1182","volume":"123","author":[{"given":"Cl\u00e9mentine","family":"Sarkozy","sequence":"first","affiliation":[{"name":"Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Service d\u2019H\u00e9matologie, Pierre-B\u00e9nite, France University Claude Bernard Lyon 1,Lyon, France"}]},{"given":"John Francis","family":"Seymour","sequence":"additional","affiliation":[{"name":"Peter MacCallum Cancer Centre, Melbourne, Australia University of Melbourne, Melbourne, Australia"}]},{"given":"Christophe","family":"Ferme","sequence":"additional","affiliation":[{"name":"Institut de Canc\u00e9rologie Gustave Roussy, Villejuif, France"}]},{"given":"Dolores","family":"Caballero","sequence":"additional","affiliation":[{"name":"Universitario de Salamanca, Salamanca, Spain"}]},{"given":"Herv\u00e9","family":"Ghesquieres","sequence":"additional","affiliation":[{"name":"Centre L\u00e9on B\u00e9rard, Lyon, France"}]},{"given":"Sirpa","family":"Leppa","sequence":"additional","affiliation":[{"name":"Helsinki University Central Hospital Cancer Center, Helsinki, Finland University of Helsinki, Helsinki, Finland"}]},{"given":"Richard","family":"Delarue","sequence":"additional","affiliation":[{"name":"Assistance Publique des H\u00f4pitaux de Paris, H\u00f4pital Necker, Paris, France Institut Imagine\u2013Universit\u00e9 Paris Cit\u00e9 Sorbonne, Paris, France"}]},{"given":"Lars Moller","family":"Pedersen","sequence":"additional","affiliation":[{"name":"Roskilde University Hospital, Roskilde, Denmark"}]},{"given":"Christiane","family":"Mounier","sequence":"additional","affiliation":[{"name":"H\u00f4pital Nord\u2013St. Priest en Jariez, Saint Etienne, France"}]},{"given":"Maria","family":"Gomes Da Silva","sequence":"additional","affiliation":[{"name":"Portuguese Institute of Oncology, Lisbon, Portugal"}]},{"given":"Catherine","family":"Chassagne-Clement","sequence":"additional","affiliation":[{"name":"Centre L\u00e9on B\u00e9rard, Lyon, France"}]},{"given":"Marie","family":"Maerevoet","sequence":"additional","affiliation":[{"name":"H\u00f4pital Erasme, Anderlecht, Belgium Universit\u00e9 Libre de Bruxelles, Brussels, Belgium"}]},{"given":"Gilles","family":"Salles","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Service d\u2019H\u00e9matologie, Pierre-B\u00e9nite, France Universit\u00e9 Claude Bernard Lyon 1, Lyon, France"}]}],"member":"234","reference":[{"key":"2019111817474958500_B1","author":"International Agency for Research on Cancer"},{"issue":"9","key":"2019111817474958500_B2","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/jcp.41.9.951","article-title":"Morphology and immunology of circulating cells in leukaemic phase of follicular lymphoma.","volume":"41","author":"Melo","year":"1988","journal-title":"J Clin Pathol"},{"issue":"2","key":"2019111817474958500_B3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1600-0609.1993.tb00149.x","article-title":"High incidence of leukemic phase in follicular lymphoma in Akita, Japan: clinicopathologic, immunological and cytogenetic studies.","volume":"50","author":"Chubachi","year":"1993","journal-title":"Eur J Haematol"},{"issue":"1","key":"2019111817474958500_B4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1385\/MO:23:1:131","article-title":"Unusual IgD+\/CD38-follicular lymphoma with leukemic presentation.","volume":"23","author":"Rymkiewicz","year":"2006","journal-title":"Med Oncol"},{"issue":"8","key":"2019111817474958500_B5","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3109\/10428194.2011.574753","article-title":"Leukemic phase of follicular lymphomas: an atypical presentation.","volume":"52","author":"Al-Nawakil","year":"2011","journal-title":"Leuk Lymphoma"},{"issue":"9759","key":"2019111817474958500_B6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0140-6736(10)62175-7","article-title":"Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial.","volume":"377","author":"Salles","year":"2011","journal-title":"Lancet"},{"issue":"5","key":"2019111817474958500_B7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/bjh.12675","article-title":"Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis.","volume":"164","author":"Sarkozy","year":"2014","journal-title":"Br J Haematol"},{"issue":"23","key":"2019111817474958500_B8","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1182\/blood-2013-06-507319","article-title":"Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program.","volume":"122","author":"Ladetto","year":"2013","journal-title":"Blood"},{"issue":"9","key":"2019111817474958500_B9","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1182\/blood-2004-03-1110","article-title":"From the bench to the bedside: ways to improve rituximab efficacy.","volume":"104","author":"Cartron","year":"2004","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/123\/17\/2740\/1376452\/2740.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/123\/17\/2740\/1376452\/2740.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T17:47:56Z","timestamp":1574099276000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/123\/17\/2740\/32543\/Rituximab-maintenance-obviates-the-poor-prognosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,24]]},"references-count":9,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2014,4,24]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2014-02-553693","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,24]]}}}